Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$173.38
+0.3%
$168.86
$108.35
▼
$182.99
$48.83B1.242.24 million shs92,825 shs
Danaher Corporation stock logo
DHR
Danaher
$227.84
-0.9%
$223.01
$160.93
▼
$242.80
$160.25B0.764.40 million shs192,457 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$691.95
+0.1%
$672.40
$435.27
▼
$727.56
$256.22B0.842.24 million shs127,076 shs
Waters Corporation stock logo
WAT
Waters
$456.02
+0.6%
$441.32
$282.77
▼
$483.33
$44.75B1.16959,094 shs35,107 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-0.57%-3.94%+0.13%+16.37%+17.76%
Danaher Corporation stock logo
DHR
Danaher
-1.36%-2.22%+0.49%+15.22%+3.95%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-1.20%-4.21%+0.19%+17.21%+19.42%
Waters Corporation stock logo
WAT
Waters
-1.62%-5.11%+3.63%+12.68%+19.19%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$173.38
+0.3%
$168.86
$108.35
▼
$182.99
$48.83B1.242.24 million shs92,825 shs
Danaher Corporation stock logo
DHR
Danaher
$227.84
-0.9%
$223.01
$160.93
▼
$242.80
$160.25B0.764.40 million shs192,457 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$691.95
+0.1%
$672.40
$435.27
▼
$727.56
$256.22B0.842.24 million shs127,076 shs
Waters Corporation stock logo
WAT
Waters
$456.02
+0.6%
$441.32
$282.77
▼
$483.33
$44.75B1.16959,094 shs35,107 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-0.57%-3.94%+0.13%+16.37%+17.76%
Danaher Corporation stock logo
DHR
Danaher
-1.36%-2.22%+0.49%+15.22%+3.95%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-1.20%-4.21%+0.19%+17.21%+19.42%
Waters Corporation stock logo
WAT
Waters
-1.62%-5.11%+3.63%+12.68%+19.19%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.82
Moderate Buy$181.454.65% Upside
Danaher Corporation stock logo
DHR
Danaher
2.78
Moderate Buy$242.916.61% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.93
Moderate Buy$683.64-1.20% Downside
Waters Corporation stock logo
WAT
Waters
2.79
Moderate Buy$475.484.27% Upside

Current Analyst Ratings Breakdown

Latest A, TMO, DHR, and WAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/4/2026
Waters Corporation stock logo
WAT
Waters
Reiterated RatingOutperform$535.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Set Price Target$470.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetBuy$470.00 ➝ $536.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetNeutral$435.00 ➝ $470.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetBuy$515.00 ➝ $530.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetOverweight$500.00 ➝ $530.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetOutperform$475.00 ➝ $525.00
11/4/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetOverweight$460.00 ➝ $500.00
10/30/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Boost Price TargetBuy$560.00 ➝ $780.00
10/28/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Lower Price TargetOutperform$720.00 ➝ $615.00
10/27/2026
Danaher Corporation stock logo
DHR
Danaher
DowngradeStrong-Buy ➝ Hold
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B7.04$6.65 per share26.09$23.78 per share7.29
Danaher Corporation stock logo
DHR
Danaher
$24.57B6.52$11.16 per share20.42$76.23 per share2.99
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$44.56B5.75$30.07 per share23.01$147.81 per share4.68
Waters Corporation stock logo
WAT
Waters
$3.17B14.16$16.40 per share27.80$155.58 per share2.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$5.0834.0925.692.5319.53%24.45%13.09%11/23/2026 (Estimated)
Danaher Corporation stock logo
DHR
Danaher
$3.61B$6.1137.2824.502.9216.91%11.17%6.71%1/27/2027 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.9636.4724.882.8514.94%17.33%8.18%2/4/2027 (Estimated)
Waters Corporation stock logo
WAT
Waters
$642.63M$2.33195.4027.502.631.75%9.91%6.11%N/A

Latest A, TMO, DHR, and WAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/23/2026Q4 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.73N/AN/AN/A$1.99 billionN/A
11/3/2026Q3 2026
Waters Corporation stock logo
WAT
Waters
$4.00$4.10+$0.10$0.82$1.75 billion$1.77 billion
10/21/2026Q3 2026
Danaher Corporation stock logo
DHR
Danaher
$1.92$2.11+$0.19$1.75$6.56 billion$6.55 billion
10/21/2026Q3 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.40$6.68+$0.28$4.64$11.95 billion$12.14 billion
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49$1.62+$0.13$1.28$1.84 billion$1.88 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.59%+6.58%20.08%9 Years
Danaher Corporation stock logo
DHR
Danaher
$1.600.70%+12.20%26.19%2 Years
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.27%+14.34%9.92%8 Years
Waters Corporation stock logo
WAT
Waters
N/AN/AN/AN/AN/A

Latest A, TMO, DHR, and WAT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/5/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.28%12/15/202612/15/20261/15/2027
9/15/2026
Danaher Corporation stock logo
DHR
Danaher
quarterly$0.400.72%9/30/20269/30/202610/30/2026
9/16/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.6%10/6/202610/6/202610/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.50
2.05
1.56
Danaher Corporation stock logo
DHR
Danaher
0.45
1.63
1.29
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.71
1.81
1.41
Waters Corporation stock logo
WAT
Waters
0.29
1.89
0.40

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Danaher Corporation stock logo
DHR
Danaher
79.05%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%
Waters Corporation stock logo
WAT
Waters
94.01%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Danaher Corporation stock logo
DHR
Danaher
10.80%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
Waters Corporation stock logo
WAT
Waters
0.31%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100281.93 millionN/AOptionable
Danaher Corporation stock logo
DHR
Danaher
60,000703.53 million627.55 millionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000370.52 million369.29 millionOptionable
Waters Corporation stock logo
WAT
Waters
7,90098.29 million97.98 millionOptionable

Recent News About These Companies

What Was Waters Telling You Before Its Stock Ran?
Crystal Waters Brings Music, Community and Giving Back
Tungsten Mining Releases Watershed Project Development Video
Watershed DFS Reports A$1.57 Billion Pre-Tax NPV
Pure waters
Waters (NYSE:WAT) Stock Dropped to Hold by Wall Street Zen
Waters (NYSE:WAT) Stock Bumped Down to "Hold" by Wall Street Zen
Pink Floyd's Roger Waters files for fifth divorce
Pink Floyd's Roger Waters files for fifth divorce

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$173.38 +0.46 (+0.27%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Danaher stock logo

Danaher NYSE:DHR

$227.84 -2.07 (-0.90%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$691.95 +0.62 (+0.09%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Waters stock logo

Waters NYSE:WAT

$456.02 +2.60 (+0.57%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.